Amgen (AMGN) Goodwill & Intangibles (2009 - 2026)
Amgen (AMGN) posted quarterly Goodwill & Intangibles of $40.1 billion for Q1 2026, up 70.84% year-over-year from $23.4 billion in Q1 2025, and down 2.2% quarter-over-quarter from $41.0 billion in Q4 2025.
Amgen (AMGN) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Amgen's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $40.1 billion for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 70.84% year-over-year to $40.1 billion; the TTM figure through Mar 2026 stood at $40.1 billion (up 70.84% YoY), while the FY2025 annual figure was $41.0 billion, down 11.61% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $40.1 billion, down from $41.0 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $51.3 billion in Q4 2023, with the low at $19.0 billion in Q2 2025.
- The 5-year median for Goodwill & Intangibles is $31.6 billion (2022), against an average of $36.3 billion.
- The sharpest annual moves came in 2025 and 2026: Goodwill & Intangibles plunged 61.01% in 2025, then soared 70.84% in 2026.
- Amgen's Goodwill & Intangibles stood at $31.6 billion in 2022, then surged by 62.2% to $51.3 billion in 2023, then fell by 9.62% to $46.3 billion in 2024, then fell by 11.61% to $41.0 billion in 2025, then retreated by 2.2% to $40.1 billion in 2026.
- Business Quant data shows AMGN's Goodwill & Intangibles at $40.1 billion in Q1 2026, $41.0 billion in Q4 2025, and $41.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.16 Bn |
| Mar 31, 2026 | 40.05 Bn |
| Dec 31, 2025 | 40.96 Bn |
| Sep 30, 2025 | 41.82 Bn |
| Jun 30, 2025 | 19.02 Bn |
| Mar 31, 2025 | 23.45 Bn |
| Dec 31, 2024 | 46.34 Bn |
| Sep 30, 2024 | 47.58 Bn |
| Jun 30, 2024 | 48.79 Bn |
| Mar 31, 2024 | 49.94 Bn |
| Dec 31, 2023 | 51.27 Bn |
| Sep 30, 2023 | 28.66 Bn |
| Jun 30, 2023 | 30.16 Bn |
| Mar 31, 2023 | 30.92 Bn |
| Dec 31, 2022 | 31.61 Bn |
| Sep 30, 2022 | 28.11 Bn |
| Jun 30, 2022 | 28.79 Bn |
| Mar 31, 2022 | 29.46 Bn |
| Dec 31, 2021 | 30.07 Bn |
| Sep 30, 2021 | 29.32 Bn |